| 11. |
Oxaliplatin-based regimen outfoxes colorectal cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 13-15
RM Poole,
Preview
|
|
摘要:
The FOLFOX4 regimen, consisting of oxaliplatin ['Eloxatin'], fluorouracil and folinic acid [leucovorin] is significantly more effective than current standard therapies for colon and colorectal cancer, according to three phase III studies presented at the 39th Annual Meeting of the American Society of Clinical Oncology [Chicago, US; May−June 2003]. The results from a major study involving over 2000 patients showed that adjuvant treatment with FOLFOX4 regimen significantly reduced the risk of cancer recurrence in patients with colon cancer, compared with the standard combination of fluorouracil and folinic acid. Mature results from two separate studies showed that the FOLFOX4 regimen was more effective than the current standard regimens for the first- and second-line treatment of metastatic colorectal cancer.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 12. |
Imatinib mesylate effectively treated 12 adults with symptomatic systemic mast cell disease |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 15-15
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 13. |
Conventional-intensity warfarin superior for VTE prophylaxis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 14. |
A higher ascorbic acid intake appears to be associated with a lower risk of coronary heart disease (CHD) in women, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 15. |
The addition of low-dose azathioprine to interferon (IFN)-β-1b may enhance response in patients with relapsing-remitting multiple sclerosis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 16. |
Clarithromycin has no measurable anti-inflammatory effect in patients with atherosclerosis, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 17. |
NSAIDs during pregnancy: increased risk of miscarriage? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 20-20
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 18. |
Guggulipid raises LDL-cholesterol levels in hypercholesterolaemia |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 21-21
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 19. |
The Australian Drug Evaluation Committee has recommended for approval Pharmion's thalidomide |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 22-22
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 20. |
Product Introductions |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 23-23
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
